Improving Patient Outcomes Begins with Confirmation Testing

Targeted Genetics Meets Enhanced Adherence Monitoring


Gain Insight


Making The Right Call Just Got Easier. Let Pharmacogenetics Guide Your Treatment.


achieve RESPONSE™


Transition To A Better Lab Solution.


explore SWIFT™


Solutions That Allow Providers To Do What They Do Best – Focus On Patients.


Our Solutions

Substance Abuse Research Alliance

LabSolutions is proud to be a member of SARA, a program of the Georgia Prevention Project.

Learn More

Secure Provider Portal

Our intuitive portal allows you to access results and request consults from anywhere.


Bi-Directional EMR Interfaces

Less time maintaining charts and requisitioning orders means more time with your patients.

Experienced Staff

Direct access to our scientists allows your team to leverage years of experience.


On-Site Specimen Collection Services

Placement of a qualified LabSolutions specimen collector saves your staff valuable time.

Flexible Reporting Preferences

Customizable patient reports delivered when and where you want them.

Eligibility and Utilization Training

The use of conservative testing protocols that focus on necessity, ensures providers are ordering responsibly.

100,000 Deaths

According to the FDA, 100,000 people die each year from adverse drug reactions. Acknowledging the impact Pharmacogenetics can have on this death toll, the FDA now lists known genetic factors on packages of 137 of its approved medications.

1,200,000 ER Visits

According to the National Institute on Drug Abuse, yearly, 1.2 million emergency visits involve the non-medical use of pharmaceuticals. The most frequently reported drugs were opiate/opioid analgesics, present in 50 percent of the non-medical-use ED visits.

$3.5 Billion in Costs

According to the CDC, adverse drug events cost the U.S. health system approximately $3.5 billion annually. The potential cost-savings of Pharmacogenetic testing is a huge possibility in healthcare today which could dramatically improve the quality and standard of care.


Comprehensive Drugs of Abusive Monitoring; perfect for treatment/abuse facilities as well as for providers managing patients with chronic pain.


A member of the VERIFY™ Drugs of Abuse testing family; includes in-depth coverage of rare illicit substances like synthetic/designer drugs.


A game-changing family of tests designed to highlight genetic variation that may alter response to drug therapies.


A comprehensive Hereditary Risk Assessment tool to uncover patients’ genetic predisposition to cancers.


Non-invasive Prenatal screening designed to detect chromosomal abnormalities. Knowing now, means options.

We Can Help

Personalized approaches to healthcare that incorporate screening and monitoring tools result in improved patient outcomes and long term cost lowering. Let our team design a custom solution for you today.

Contact Us